This invention relates to compounds of Formula (1) or a pharmaceutically acceptable salt, solvate or isomer thereof, which can be useful for the treatment of diseases or conditions mediated by MMPs, ADAMs, TACE, TNF- or combinations thereof.
该发明涉及式(1)化合物或其药用可接受的盐、溶剂合物或异构体,可用于治疗由MMPs、A
DAMs、TACE、TNF-或其组合介导的疾病或症状。